April 2020: an ambulance picks up a possible covid patient near Liège. Whether the pill really makes a difference – and thus reduces the risk of hospitalization – will be known in September or October. — © afp
The drug company Merck is investigating whether molnupiravir can prevent the first symptoms from derailing into severe covid-19. It is one of the few drugs in the pipeline to avoid hospital admissions.
Read Also
- Edible Tomato Vaccine? Researchers make important discoveries Sep 14, 2021
- Savoie: Drug trafficker sentenced to seven years in prison Nov 23, 2022
- Top 10 foods to enhance mental performance Aug 16, 2020
- Redon: Hospital and 3,000 homes without water after pipe burst Dec 6, 2022
- Military exercise of unprecedented scale in France in 2023 Nov 17, 2022
- Vaccines, Hope: “Today we will exceed 64 million doses administered” Jul 23, 2021
- Oxford Recovery Trial – A pharmacokinetic model wrong leading to the overdose Jul 3, 2020
Maxie Eckert
Today at 11:34 AM
.
